Page last updated: 2024-08-21

fluorobenzenes and Ambulation Disorders, Neurologic

fluorobenzenes has been researched along with Ambulation Disorders, Neurologic in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Corso, T; Dziewiatkowski, J; Hesse, RA; Klejbor, I; Kucinski, A; Miletich, R; Moryƛ, J; Rice, KC; Spodnik, JH; Stachowiak, EK; Stachowiak, MK; Wersinger, SR1
Barr, AM; Caron, MG; Gainetdinov, RR; Geyer, MA; Lehmann-Masten, V; Paulus, M1

Other Studies

2 other study(ies) available for fluorobenzenes and Ambulation Disorders, Neurologic

ArticleYear
Serotonergic hyperinnervation and effective serotonin blockade in an FGF receptor developmental model of psychosis.
    Schizophrenia research, 2009, Volume: 113, Issue:2-3

    Topics: Animals; Animals, Newborn; Antipsychotic Agents; Behavior, Animal; Disease Models, Animal; Exploratory Behavior; Female; Fluorobenzenes; Gait Disorders, Neurologic; Grooming; Hydroxyindoleacetic Acid; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Neural Inhibition; Piperidines; Protein-Tyrosine Kinases; Psychotic Disorders; Rats; Receptors, Fibroblast Growth Factor; Reflex, Startle; Serotonin; Serotonin Antagonists; Social Behavior

2009
The selective serotonin-2A receptor antagonist M100907 reverses behavioral deficits in dopamine transporter knockout mice.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2004, Volume: 29, Issue:2

    Topics: Acoustic Stimulation; Analysis of Variance; Animals; Dopamine Plasma Membrane Transport Proteins; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Fluorobenzenes; Gait Disorders, Neurologic; Inhibition, Psychological; Locomotion; Membrane Glycoproteins; Membrane Transport Proteins; Mental Disorders; Mice; Mice, Knockout; Nerve Tissue Proteins; Piperidines; Reflex, Acoustic; Reversal Learning; Serotonin 5-HT2 Receptor Antagonists; Spatial Behavior

2004